EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Senopathies—Diseases Associated with Cellular Senescence

Oleh Lushchak iD, Markus Schosserer iD, Johannes Grillari iD

Biomolecules · 08.06.2023 · 13 (6) · 966

DOI: 10.3390/biom13060966 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomolecules, online erschienen am 08.06.2023. Verfasst von Oleh Lushchak und 2 weiteren Autor:innen. Beteiligte Einrichtung: Ludwig Boltzmann Institute for Traumatology, The Research Center in Cooperation with AUVA, 1200 Vienna, Austria. Hauptthemen laut MEDLINE: Cellular Senescence, Aging. Die Arbeit wurde bisher 38-mal zitiert (Crossref) und nennt 84 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Austrian Science Fund FWF, Austrian Science Fund (FWF), ‘Herzfelder’sche Familienstiftung.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cellular senescence describes a stable cell cycle arrest state with a characteristic phenotype. Senescent cells accumulate in the human body during normal aging, limiting the lifespan and promoting aging-related, but also several non-related, pathologies. We propose to refer to all diseases whose pathogenesis or progression is associated with cellular senescence as “senopathies”. Targeting senescent cells with senolytics or senomorphics is likely to mitigate these pathologies. Examples of senopathies include cardiovascular, metabolic, musculoskeletal, liver, kidney, and lung diseases and neurodegeneration. For all these pathologies, animal studies provide clear mechanistic evidence for a connection between senescent cell accumulation and disease progression. The major persisting challenge in developing novel senotherapies is the heterogeneity of senescence phenotypes, causing a lack of universal biomarkers and difficulties in discriminating senescent from non-senescent cells.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cellular SenescenceAgingAnimalsHumansBiomarkersLungPhenotype

Stichwörter der Autor:innen

age-related diseaseagingcellular senescencegerosciencepathologysenescence-associated secretory phenotype (SASP)senolyticsenomorphicsenopathysenotherapy

Substanzen

Biomarkers

Autor:innen und Institutionen

  • Ludwig Boltzmann Institute for Traumatology, The Research Center in Cooperation with AUVA, 1200 Vienna, Austria.
  • Department of Biochemistry and Biotechnology, Precarpathian National University, 76000 Ivano-Frankivsk, Ukraine.
  • Research and Development University, 76018 Ivano-Frankivsk, Ukraine.
  • Institute of Medical Genetics, Center for Pathobiochemistry and Genetics, Medical University of Vienna, 1090 Vienna, Austria.
  • Austrian Cluster for Tissue Regeneration, 1200 Vienna, Austria.
  • Institute of Molecular Biotechnology, Department of Biotechnology, University of Natural Resources and Life Sciences, 1190 Vienna, Austria.

ORCID-Profile: Oleh Lushchak, Markus Schosserer, Johannes Grillari

Förderung

  • Austrian Science Fund FWF
  • Austrian Science Fund (FWF)
  • ‘Herzfelder’sche Familienstiftung

Zitieren

APA

Lushchak, O., Schosserer, M., & Grillari, J. (2023). Senopathies—Diseases Associated with Cellular Senescence. Biomolecules, 13(6), 966. https://doi.org/10.3390/biom13060966

Vancouver

Lushchak O, Schosserer M, Grillari J. Senopathies—Diseases Associated with Cellular Senescence. Biomolecules. 2023;13(6):966. doi:10.3390/biom13060966

BibTeX
@article{Lushchak2023,
  author = {Lushchak, Oleh and Schosserer, Markus and Grillari, Johannes},
  title = {Senopathies—Diseases Associated with Cellular Senescence},
  journal = {Biomolecules},
  year = {2023},
  volume = {13},
  number = {6},
  pages = {966},
  doi = {10.3390/biom13060966}
}
Kostenlos starten →